Choose your sales office

News

ELITechGroup

Filter

Open filter menu
Reset
Reset

ELITechGroup’s Vitamin D reagents; ready-to-use chemistry for efficiency

Vitamin D is a fat-soluble steroid hormone that is required for the intestinal absorption of calcium, maintenance of calcium homeostasis, and protection against osteomalacia i.e. softening of the bones. Vitamin D deficiency can lead to loss of bone density which can contribute to osteoporosis (reduction in bone mass) and fractures…
READ MORE

ELITechGroup’s Cholinesterase – an economical option for low-volume testing

The primary role of Cholinesterase in Clinical Diagnostics is to detect or monitor an acquired or inherited pseudocholinesterase deficiency. Pseudocholinesterase deficiency is a condition that causes increased sensitivity to certain muscle relaxant drugs used during general anesthesia (choline esters). These drugs relax the muscles used for movement, including those used…
READ MORE

ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories

HypoxE® Test allows for the early detection of Hypoxic-Ischemic Encephalopathy (HIE) caused by lack of oxygen during birth ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers Chicago, IL, USA, July 27, 2022 – ELITechGroup and InfanDx AG…
READ MORE

IVDR compliance at ELITechGroup Clinical Chemistry

As a European-based (EU) manufacturer of IVD products, used in clinical diagnostic laboratories throughout the world, the introduction of the EU’s IVDR is of paramount importance for ELITechGroup’s Clinical Systems division. European Invitro Diagnostic Medical Device Regulations (IVDR) The IVDR will replace the existing In Vitro Diagnostic Medical Devices Directive…
READ MORE

NEW ELITechGroup Lactate Reagent

ELITechGroup Clinical Systems is pleased to announce the introduction of another new reagent, Lactate, to the growing range of reagents for the Selectra Pro and Mach systems. Lactate is a metabolite of glucose, produced during conditions of insufficient oxygen supply (e.g. rapid exercise). Most Lactate is produced by skeletal muscle…
READ MORE

NGSP Recertification of HbA1c methods for Selectra Pro M and Pro S

According to the 9th Edition of the IDF Diabetes Atlas 463 million adults (20-79 years) have Diabetes and based on current trends this number is expected to reach 700 million by 2045. ​It is estimated almost 232 million people have undiagnosed diabetes (2019). ​So, it is not surprising that Diabetes…
READ MORE

Hospital Artificial Intelligence

Artificial intelligence (AI) is being utilized in many different walks of life these days to improve people’s lives. From vehicles that are able to drive themselves to smartphones that react to the commands people give them and provide them with the information they need, AI has come a long way…
READ MORE

New Heart Failure Treatment Possibility

The number of people suffering from heart failure is expected to increase almost 50 percent over the course of the next 15 years. This is very troubling because, as of right now, about half of those who suffer from heart failure die within five years of being diagnosed. Their heart…
READ MORE